Salivary Gland Disorders
Mucoepidermoid Carcinoma
aka MEC
The most common malignant salivary gland tumour; composed of mucous, intermediate and epidermoid cells with CRTC1/MAML2 fusion driving pathogenesis.
§ overviewOverview
Malignant epithelial salivary gland neoplasm characterised by variable proportions of mucous, intermediate and squamoid cells.
§ icdICD Classification
C07/C08
§ etiologyEtiology
- 01Sporadic; ionising radiation increases risk
- 02CRTC1(MECT1)-MAML2 fusion in ≈50–70%
§ epidemiologyEpidemiology
≈30% of salivary malignancies; parotid > minor glands (palate); commonest salivary malignancy in children.
§ clinicalClinical Features
- 01Painless slow-growing swelling (low grade) — may mimic mucocele on palate
- 02Rapidly growing painful mass with fixation, facial nerve palsy (high grade)
- 03Fluctuant bluish palatal swelling common
§ differentialDifferential Diagnosis
- 01Pleomorphic adenoma
- 02Mucocele (minor glands)
- 03Adenoid cystic carcinoma
- 04SCC
§ histopathHistopathology
- 01Mixture of mucous (goblet), intermediate and epidermoid cells
- 02Cystic spaces (low grade) → solid sheets with atypia (high grade)
- 03Mucicarmine and PAS-diastase stain mucous cells
§ investigationsInvestigations
- 01MRI (soft-tissue detail, perineural spread)
- 02FNAC / core biopsy
- 03CT chest for staging
§ ihcIHC / Special Stains
- 01CK7+, p63 in epidermoid cells
- 02MAML2 FISH for confirmation
§ classificationClassification
- 01Grading systems: AFIP, Brandwein, MSK — based on cystic component, invasion, necrosis, mitoses, perineural spread
- 02Low, intermediate, high grade
§ treatmentTreatment
- 01Wide local excision with clear margins
- 02Parotid: superficial or total parotidectomy with facial nerve preservation
- 03Neck dissection for high-grade / cN+
- 04Adjuvant radiotherapy for high-grade, positive margins, perineural or vascular invasion
- 05Chemotherapy for palliation
§ complicationsComplications
- 01Facial nerve injury
- 02Recurrence (high grade)
- 03Distant metastases (lung, bone) in high-grade
§ prognosisPrognosis
5-year survival: low grade >90%, intermediate ~70%, high grade 30–50%.
§ examKey Examination Points
- 01Bluish palatal swelling in adult → not a mucocele until proven otherwise
- 02Always image before biopsy of parotid mass
§ revisionQuick Revision Summary
- 01MAML2 fusion · commonest paediatric salivary malignancy · grade determines prognosis
§ vivaBDS Viva Questions
- 01Diagnostic translocation of MEC?
- 02Grading criteria?
- 03Approach to parotid MEC?
§ mcqsMCQs — Assessment (3)
Question 1
Most common malignant salivary gland tumour:
Question 2
Characteristic gene fusion:
Question 3
Commonest intraoral site:
References
- WHO Head & Neck Tumours 2022
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.